Epithelial-mesenchymal Transition Status is a Remarkable Biomarker for the Combination Treatment with Avutometinib and Defactinib in KRAS-mutated Non-Small Cell Lung Cancer
BRITISH JOURNAL OF CANCER（2024）
关键词
Cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要